日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay.

利用 CA15-3 捕获抗体-凝集素夹心法改进乳腺癌诊断

Nikseresht S, Shewell L K, Day C J, Jennings M P, Chittoory H, McCart Reed A E, Simpson P T, Lakhani S R, Nabiee R, Moore M, Khanabdali R, Hinch L M, Rice G E

Hereditary breast cancer: syndromes, tumour pathology and molecular testing

遗传性乳腺癌:综合征、肿瘤病理学和分子检测

Sokolova, A; Johnstone, K J; McCart Reed, A E; Simpson, P T; Lakhani, S R

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

OlympiA III期临床试验中,奥拉帕尼辅助治疗对携带BRCA1/2种系致病性变异的高危早期乳腺癌患者的总生存期

Geyer, C E Jr; Garber, J E; Gelber, R D; Yothers, G; Taboada, M; Ross, L; Rastogi, P; Cui, K; Arahmani, A; Aktan, G; Armstrong, A C; Arnedos, M; Balmaña, J; Bergh, J; Bliss, J; Delaloge, S; Domchek, S M; Eisen, A; Elsafy, F; Fein, L E; Fielding, A; Ford, J M; Friedman, S; Gelmon, K A; Gianni, L; Gnant, M; Hollingsworth, S J; Im, S-A; Jager, A; Jóhannsson, Ó Þ; Lakhani, S R; Janni, W; Linderholm, B; Liu, T-W; Loman, N; Korde, L; Loibl, S; Lucas, P C; Marmé, F; Martinez de Dueñas, E; McConnell, R; Phillips, K-A; Piccart, M; Rossi, G; Schmutzler, R; Senkus, E; Shao, Z; Sharma, P; Singer, C F; Španić, T; Stickeler, E; Toi, M; Traina, T A; Viale, G; Zoppoli, G; Park, Y H; Yerushalmi, R; Yang, H; Pang, D; Jung, K H; Mailliez, A; Fan, Z; Tennevet, I; Zhang, J; Nagy, T; Sonke, G S; Sun, Q; Parton, M; Colleoni, M A; Schmidt, M; Brufsky, A M; Razaq, W; Kaufman, B; Cameron, D; Campbell, C; Tutt, A N J

Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers

全基因组测序揭示了家族性乳腺癌病因学中具有临床意义的见解

Nones, K; Johnson, J; Newell, F; Patch, A M; Thorne, H; Kazakoff, S H; de Luca, X M; Parsons, M T; Ferguson, K; Reid, L E; McCart Reed, A E; Srihari, S; Lakis, V; Davidson, A L; Mukhopadhyay, P; Holmes, O; Xu, Q; Wood, S; Leonard, C; Beesley, J; Harris, J M; Barnes, D; Degasperi, A; Ragan, M A; Spurdle, A B; Khanna, K K; Lakhani, S R; Pearson, J V; Nik-Zainal, S; Chenevix-Trench, G; Waddell, N; Simpson, P T

COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment

COX-2表达可预测乳腺导管原位癌患者的早期复发和芳香化酶抑制剂耐药性,是治疗靶点。

Generali, D; Buffa, F M; Deb, S; Cummings, M; Reid, L E; Taylor, M; Andreis, D; Allevi, G; Ferrero, G; Byrne, D; Martinotti, M; Bottini, A; Harris, A L; Lakhani, S R; Fox, S B

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

对三阴性乳腺癌全球基因表达谱的荟萃分析,鉴定出可用于预测和治疗侵袭性乳腺癌的基因

Al-Ejeh, F; Simpson, P T; Saunus, J M; Klein, K; Kalimutho, M; Shi, W; Miranda, M; Kutasovic, J; Raghavendra, A; Madore, J; Reid, L; Krause, L; Chenevix-Trench, G; Lakhani, S R; Khanna, K K

Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers

绘制 BRCA1/2 基因携带者正常人乳腺细胞中杂合性缺失的图谱

Clarke, C L; Sandle, J; Jones, A A; Sofronis, A; Patani, N R; Lakhani, S R

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast

乳腺纯导管原位癌治疗后复发性原位癌和浸润性癌的分级

Millis, R R; Pinder, S E; Ryder, K; Howitt, R; Lakhani, S R

Expression of ATM, p53, and the MRE11-Rad50-NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast

乳腺良性和恶性增生性肌上皮细胞中 ATM、p53 和 MRE11-Rad50-NBS1 复合物的表达

Angèle, S; Jones, C; Reis Filho, J S; Fulford, L G; Treilleux, I; Lakhani, S R; Hall, J

CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation

乳腺导管癌基底样/肌上皮细胞分化的CGH分析

Jones, C; Nonni, A V; Fulford, L; Merrett, S; Chaggar, R; Eusebi, V; Lakhani, S R